Cancer Therapy with Radiolabeled Antibodies explores experimental and clinical advances in the field of cancer radioimmunotherapy (RAIT). In this work, leading experts examine the problems and prospects of RAIT; from radiation, immunological, chemical, physical, physiological, and clinical perspectives with both overviews and original research.